Cargando…

LncRNAs LY86-AS1 and VIM-AS1 Distinguish Plasma Cell Leukemia Patients from Multiple Myeloma Patients

Long non-coding RNAs (lncRNAs) are functional RNAs longer than 200 nucleotides. Due to modern genomic techniques, the involvement of lncRNAs in tumorigenesis has been revealed; however, information concerning lncRNA interplay in multiple myeloma (MM) and plasma cell leukemia (PCL) is virtually absen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bútová, Romana, Vychytilová-Faltejsková, Petra, Gregorová, Jana, Radová, Lenka, Almáši, Martina, Bezděková, Renata, Brožová, Lucie, Jarkovský, Jiří, Knechtová, Zdeňka, Štork, Martin, Pour, Luděk, Ševčíková, Sabina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615960/ https://www.ncbi.nlm.nih.gov/pubmed/34829867 http://dx.doi.org/10.3390/biomedicines9111637

Ejemplares similares

Involvement of Small Non-Coding RNA and Cell Antigens in Pathogenesis of Extramedullary Multiple Myeloma
por: Vlachová, Monika, et al.
Publicado: (2022)

Necessity of flow cytometry assessment of circulating plasma cells and its connection with clinical characteristics of primary and secondary plasma cell leukaemia
por: Bezdekova, Renata, et al.
Publicado: (2021)

Circulating exosomal long noncoding RNA PRINS—First findings in monoclonal gammopathies
por: Sedlarikova, Lenka, et al.
Publicado: (2018)

Epigenetic Regulation of MicroRNA Clusters and Families during Tumor Development
por: Gregorova, Jana, et al.
Publicado: (2021)

Long Non-Coding RNAs in Multiple Myeloma
por: Butova, Romana, et al.
Publicado: (2019)

Dynamics of tumor‐specific cfDNA in response to therapy in multiple myeloma patients
por: Vrabel, David, et al.
Publicado: (2019)

Outcome of COVID-19 infection in 50 multiple myeloma patients treated with novel drugs: single-center experience
por: Krejci, Marta, et al.
Publicado: (2021)

Unexpected Heterogeneity of Newly Diagnosed Multiple Myeloma Patients with Plasmacytomas
por: Stork, Martin, et al.
Publicado: (2022)

Mutational analysis of primary and metastatic colorectal cancer samples underlying the resistance to cetuximab-based therapy
por: Nemecek, Radim, et al.
Publicado: (2016)

Identification of patients at high risk of secondary extramedullary multiple myeloma development
por: Stork, Martin, et al.
Publicado: (2021)

Circulating Serum MicroRNA-130a as a Novel Putative Marker of Extramedullary Myeloma
por: Besse, Lenka, et al.
Publicado: (2015)

Daratumumab with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma patients – real world evidence analysis
por: Stork, Martin, et al.
Publicado: (2023)

Rapid discrimination of multiple myeloma patients by artificial neural networks coupled with mass spectrometry of peripheral blood plasma
por: Deulofeu, Meritxell, et al.
Publicado: (2019)

Proteasome inhibitors – molecular basis and current perspectives in multiple myeloma
por: Kubiczkova, Lenka, et al.
Publicado: (2014)

More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia–Like Multiple Myeloma
por: Jelinek, Tomas, et al.
Publicado: (2023)

MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab
por: Mlcochova, Jitka, et al.
Publicado: (2015)

Higher expression of PLEK and LY86 as the potential biomarker of carotid atherosclerosis
por: Zhao, Man, et al.
Publicado: (2023)

PB1974: MULTIVARIATE SPECTRAL BIOTYPING OF EXTRAMEDULLARY MULTIPLE MYELOMA
por: Vlachová, M., et al.
Publicado: (2022)

MiR-215-5p is a tumor suppressor in colorectal cancer targeting EGFR ligand epiregulin and its transcriptional inducer HOXB9
por: Vychytilova-Faltejskova, Petra, et al.
Publicado: (2017)

Centrosome associated genes pattern for risk sub-stratification in multiple myeloma
por: Kryukov, Fedor, et al.
Publicado: (2016)

Mastering Vim: build a software development environment with Vim and Neovim
por: Osipov, Ruslan
Publicado: (2018)

Modern Vim: craft your development environment with Vim 8 and Neovim
por: Neil, Drew
Publicado: (2018)

Ditching Vim for Kakoune
por: Vasek, Robert
Publicado: (2023)

Hacking Vim 72
por: Schulz, Kim
Publicado: (2010)

The VimL Primer: edit like a pro with Vim plugins and scripts
por: Klein, Benjamin, et al.
Publicado: (2015)

MicroRNAs in urine are not biomarkers of multiple myeloma
por: Sedlaříková, Lenka, et al.
Publicado: (2015)

Long non-coding RNA ZFAS1 interacts with CDK1 and is involved in p53-dependent cell cycle control and apoptosis in colorectal cancer
por: Thorenoor, Nithyananda, et al.
Publicado: (2015)

Learning the vi and Vim Editors
por: Robbins, Arnold
Publicado: (2021)

Learning the vi and Vim Editor
por: Robbins, Arnold, et al.
Publicado: (2008)

Integrating GWAS with bulk and single-cell RNA-sequencing reveals a role for LY86 in the anti-Candida host response
por: de Vries, Dylan H., et al.
Publicado: (2020)

Benefits and Risks of a Staged‐Bilateral VIM Versus Unilateral VIM DBS for Essential Tremor
por: Prakash, Prarthana, et al.
Publicado: (2022)

Characterization of two novel VIM-type metallo-β-lactamases, VIM-84 and VIM-85, associated with the spread of IncP-2 megaplasmids in Pseudomonas aeruginosa
por: Wang, Nanfei, et al.
Publicado: (2023)

Chromothripsis 18 in multiple myeloma patient with rapid extramedullary relapse
por: Smetana, Jan, et al.
Publicado: (2018)

Validation of multiple myeloma risk stratification indices in routine clinical practice: Analysis of data from the Czech Myeloma Group Registry of Monoclonal Gammopathies
por: Radocha, Jakub, et al.
Publicado: (2018)

Comparing Programming Sessions of Vim-DBS
por: Reitz, Sarah C., et al.
Publicado: (2020)

Crystal structures of VIM‐1 complexes explain active site heterogeneity in VIM‐class metallo‐β‐lactamases
por: Salimraj, Ramya, et al.
Publicado: (2018)

Identification and functional screening of microRNAs highly deregulated in colorectal cancer
por: Faltejskova, Petra, et al.
Publicado: (2012)

Draft Whole-Genome Sequence of VIM-1-Producing Multidrug-Resistant Enterobacter cloacae EC_38VIM1
por: Villa, Jennifer, et al.
Publicado: (2013)

Genome-Wide Screening of Cytogenetic Abnormalities in Multiple Myeloma Patients Using Array-CGH Technique: A Czech Multicenter Experience
por: Smetana, Jan, et al.
Publicado: (2014)

Distinct lymphocyte antigens 6 (Ly6) family members Ly6D, Ly6E, Ly6K and Ly6H drive tumorigenesis and clinical outcome
por: Luo, Linlin, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_04l3kk4lm6ninmgjua4rq6s2vc